Study guide
11.2 Surgical Management
Certified Pediatric Hematology Oncology Nurse CPHON®
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Eligibility, Application, and Testing Logistics 1.3 Test Content Outline and Study Strategy
2 Care Continuum
2.1 Transition of Care: Primary Care and Levels of Care 2.2 End-of-Life Care 2.3 Health Promotion and Maintenance 2.4 Survivorship
3 Leukemias and Lymphomas
3.1 Acute Lymphoblastic Leukemia 3.2 Acute Myeloid Leukemia and Related Myeloid Disease 3.3 Hodgkin and Non-Hodgkin Lymphomas
4 CNS, Neuroblastoma, and Renal Tumors
4.1 Central Nervous System Tumors 4.2 Neuroblastoma 4.3 Wilms Tumor and Other Renal Tumors
5 Sarcomas and Other Solid Tumors
5.1 Osteosarcoma and Ewing Sarcoma 5.2 Rhabdomyosarcoma and Soft-Tissue Sarcomas 5.3 Retinoblastoma, Hepatoblastoma, and Germ Cell Tumors
6 Hematologic Disorders
6.1 Sickle Cell Disease 6.2 Thalassemia and Other Hemoglobinopathies 6.3 Hemophilia, von Willebrand Disease, and Coagulopathies 6.4 Immune Thrombocytopenia, Aplastic Anemia, and Bone Marrow Failure
7 Pathophysiology, Genetics, and Diagnostics
7.1 Anatomy, Physiology, and Pathophysiology Foundations 7.2 Genetics and Genomics 7.3 Diagnostic Testing, Staging, and Prognosis
8 Clinical Trials and Professional Performance
8.1 Clinical Trials and Informed Consent 8.2 Scope, Standards, and Regulatory Practice 8.3 Ethics and Patient-Family Education
9 Chemotherapy and Biotherapy
9.1 Chemotherapy Principles, Classes, and Pediatric Protocols 9.2 Safe Handling, Administration, and Vesicant Precautions 9.3 Biotherapy
10 Immunotherapy, Cellular Therapy, and Radiation
10.1 Immunotherapy 10.2 Cellular Therapies including CAR-T 10.3 Radiation Therapy, I-131-MIBG, and Proton Beam
11 HSCT, Surgery, Transfusion, and Coagulation Therapy
11.1 Hematopoietic Stem Cell Transplantation 11.2 Surgical Management 11.3 Blood Product Therapy, Leukapheresis, and Coagulation Therapy
12 Neurologic, Respiratory, and Cardiovascular Effects
12.1 Neurological Acute, Chronic, and Late Effects 12.2 Respiratory and Lymphatic Effects 12.3 Cardiovascular Effects
13 Gastrointestinal, Renal, Musculoskeletal, and Integumentary Effects
13.1 Gastrointestinal Effects 13.2 Renal and Genitourinary Effects 13.3 Musculoskeletal and Integumentary Effects
14 Endocrine, Hematologic, Immunologic, and Sensory Effects
14.1 Endocrine and Reproductive Effects 14.2 Hematological and Immunological Effects 14.3 Ophthalmological and Otological Effects
15 Pain, Sleep, Fatigue, and Mental Health
15.1 Pain Assessment and Management 15.2 Sleep Disturbance and Fatigue 15.3 Mental Health Effects
16 Supportive Care
16.1 Medical Devices: Venous Access, Pumps, Shunts, and Tubes 16.2 Blood Product Administration 16.3 Colony-Stimulating Factors 16.4 Interdisciplinary, Palliative, and Complementary Care
17 Infectious and Gastrointestinal Emergencies
17.1 Sepsis 17.2 Typhlitis 17.3 Pancreatitis and Bowel Obstruction
18 Metabolic Emergencies
18.1 Diabetes Insipidus and SIADH 18.2 Tumor Lysis Syndrome 18.3 Cytokine Release Syndrome
19 DIC, Hyperleukocytosis, and Sinusoidal Obstructive Syndrome
19.1 Disseminated Intravascular Coagulation and Hemorrhage 19.2 Hyperleukocytosis 19.3 Sinusoidal Obstructive Syndrome (Veno-Occlusive Disease)
20 Sickle Cell and Hemostasis Emergencies
20.1 Splenic Sequestration 20.2 Vaso-Occlusive Crisis 20.3 Stroke, Thrombosis, and Joint Bleed
21 Cardiopulmonary Emergencies
21.1 Acute Chest Syndrome 21.2 Respiratory Distress and Mediastinal Mass 21.3 Pleural Effusions and Arrhythmias
22 Neurologic and Infusion Emergencies
22.1 Increased Intracranial Pressure 22.2 Seizures and PRES 22.3 Spinal Cord Compression 22.4 Hypersensitivity Reactions and Extravasation
23 Family, Caregivers, and Social Integration
23.1 Effects of Acute and Chronic Illness on Patient and Family 23.2 Patient and Family/Caregiver Support 23.3 Integration into Family, School, Work, Camp, and Social Environment
24 Development, Grief, Culture, and Community Resources
24.1 Principles of Growth and Development 24.2 Grief and Bereavement 24.3 Culture, Sexuality and Gender, Socioeconomics, and Community Resources
11.2 Surgical Management
Key Takeaways Explain This Topic AI
Pediatric oncology surgery includes diagnostic biopsy, oncologic resection, and staging or second-look procedures, plus supportive operations such as ports and gastrostomy tubes.
Nephrectomy, laminectomy or laminotomy for cord compression, delayed primary resection after neoadjuvant chemotherapy, and limb salvage versus amputation are high-yield local-control operations.
ANC and platelet thresholds for the operating room are protocol- and surgeon-specific; do not send a profoundly thrombocytopenic child to the OR without a product plan.
An anterior mediastinal mass can collapse the airway under induction anesthesia; obtain upright imaging when possible and do not sedate until an airway plan exists.
Teach ostomy and solitary-kidney care, watch postoperative pain, ileus, and wound infection in neutropenic children, and raise fertility-preserving surgery including oophoropexy before pelvic radiation.
Last updated: August 2026
Pediatric oncology surgery is CPHON Domain III.A.6 and III.B.8: biopsy versus resection versus staging, the operations that enable treatment (ports, gastrostomy tubes), the operations that are the treatment (nephrectomy, limb salvage, laminectomy), and the peri-operative traps that kill children—airway collapse under anesthesia with a mediastinal mass, and sending a profoundly thrombocytopenic child to the operating room without a transfusion plan.
Biopsy, resection, staging, and the procedures that make treatment possible
Diagnostic biopsy obtains histology, genetics, and risk assignment. The tract should sit inside a future resection field whenever sarcoma or other solid tumors make that relevant—orthopedic oncology owns bone-sarcoma biopsy for that reason. Resection aims for oncologic local control: complete, microscopic residual, or planned delayed resection after chemotherapy shrinks the mass. Staging surgery samples nodes, inspects peritoneal surfaces, or confirms residual disease after therapy ( second-look ).
Supportive operations are not optional extras:
An implanted port or other central venous access for chemotherapy, blood products, and nutrition.
A gastrostomy tube (G-tube) when mucositis, radiation, or neurologic injury will make oral calories unsafe or inadequate.
Nephrectomy for typical U.S. Children's Oncology Group–style Wilms tumor when the mass is resectable up front (SIOP-style neoadjuvant chemotherapy before nephrectomy is a different cooperative-group philosophy—see the Wilms section).
Laminectomy or laminotomy for spinal cord compression (neuroblastoma dumbbell tumor, epidural sarcoma, or vertebral metastasis) when the team chooses surgical decompression rather than, or in addition to, emergency chemotherapy, steroids, and radiation.
Delayed primary resection after neoadjuvant chemotherapy is the bone-sarcoma and many neuroblastoma and rhabdomyosarcoma script: chemo first, then surgery on a smaller, better-defined mass.
Limb salvage (wide resection plus endoprosthesis, allograft, or rotationplasty) is preferred for extremity osteosarcoma and many Ewing tumors when an oncologically adequate, usable limb can be preserved; amputation remains correct when neurovascular structures cannot be spared.
A 14-year-old with distal femoral osteosarcoma should hear limb salvage versus amputation as a function-and-margin conversation, not as a consolation prize. A 15-month-old who suddenly cannot walk from a paraspinal neuroblastoma needs emergency imaging and a cord plan that may include laminectomy the same night.
Operation Typical pediatric role Nursing emphasis
Diagnostic biopsy Histology and genetics; tract inside future field when relevant Do not freelance a sarcoma biopsy on the floor
- Port / central access Chemo, products, nutrition Line care starts in the OR handoff
- G-tube Durable enteral access Family teaching before discharge
Nephrectomy Wilms local control when resectable up front (COG-style) Solitary-kidney protection, blood pressure
Laminectomy / laminotomy Cord compression Neurovascular checks, bladder function
Delayed primary resection After neoadjuvant chemo in bone sarcoma, many neuroblastomas Counts, wound, residual-disease teaching
- Limb salvage vs amputation Extremity sarcoma local control Endoprosthesis precautions, function
- Second-look Residual disease after chemotherapy Information, not proof the first operation failed
- Oophoropexy Move ovary out of a planned radiation field Fertility conversation before the beam
- Counts, anesthesia, and the mediastinal-mass disaster
Absolute neutrophil count and platelet thresholds for the operating room are protocol- and surgeon-specific. Do not memorize a single national ANC or platelet number as ONCC fact. The nursing rule that is testable: do not send a profoundly thrombocytopenic child to the operating room without a plan —product in the room, a working line, a type-and-screen, and an agreed platelet goal for that procedure. A 6-year-old with platelets of "too low to count" and a scheduled central-line repair at 07:00 needs platelets timed to incision, not a hope that the count will rise in the elevator.
Anterior mediastinal masses (T-lymphoblastic lymphoma or leukemia, Hodgkin lymphoma, germ-cell tumors) are an airway disaster under induction anesthesia . When muscle tone is lost, the mass compresses trachea and great vessels; the child who sat talking in the waiting room cannot be ventilated supine. Nursing stance:
Obtain upright imaging (chest radiograph and upright CT when the child can tolerate it).
Do not sedate for "a quick biopsy" until anesthesia, oncology, and, when needed, otolaryngology or extracorporeal-support teams have an airway plan .
Prefer the least anesthesia possible: peripheral blood, pleural fluid, or a carefully planned sitting biopsy rather than casual deep sedation.
A 12-year-old with T-ALL, orthopnea, and a huge anterior mediastinal mass who is "just going to CT asleep" is a preventable arrest. Sit the child up. Call anesthesia. Delay the pretty scan if the airway is not planned.
Second-look, ostomy and nephrectomy teaching, pain and infection
Second-look surgery inspects residual disease after chemotherapy—classic in selected neuroblastoma and some ovarian or germ-cell pathways. Families should hear that "second look" is information and possible further resection, not proof that the first operation failed.
Nephrectomy teaching : flank or abdominal incision care, remaining-kidney protection (no contact sports that risk the solitary kidney per team advice, blood-pressure follow-up, avoid unnecessary nephrotoxins), and that one healthy kidney can sustain a child. Ostomy teaching after pelvic rhabdomyosarcoma, extensive bowel surgery, or typhlitis-related diversion: pouch changes, peristomal skin, hydration, and when output or discoloration is an emergency. A 4-year-old with a new colostomy after pelvic surgery needs a parent who can empty the bag before discharge, not a laminated diagram left in the chart.
Pain after laparotomy or thoracotomy is multimodal: age-appropriate opioids, acetaminophen, regional techniques when infection and counts allow, and attention to ileus . Neutropenic, opioid-exposed, vincristine-treated children get constipated and then obstructed. A silent, distended abdomen on postoperative day 3 is not "sleeping off anesthesia."
Wound infection in a neutropenic child is subtle: redness may be faint, fever may be the only sign, and dehiscence risk is real. Do not wait for copious pus. Culture, notify surgery, start protocol antibiotics, and keep the wound visible. A 5-year-old on day 8 after delayed neuroblastoma resection with an ANC of 80/µL and a 38.5°C fever has a surgical-site emergency until proven otherwise, even if the dressing looks "pretty clean."
Fertility-preserving surgery
When pelvic or abdominal radiation or gonad-toxic therapy is planned, oophoropexy (ovarian transposition out of the radiation field) and other fertility-preserving procedures belong in the pre-treatment conversation, not after the beam is done. Sperm banking for pubertal boys, ovarian-tissue discussions per institutional fertility programs, and honest documentation that options were offered are nursing advocacy as much as surgical technique. Mention the concept; do not invent a single national age cutoff as ONCC fact. A 13-year-old girl facing pelvic radiation for rhabdomyosarcoma should meet fertility specialists while the ovaries can still be moved, not at a survivorship visit five years later.
The CPHON product is a child whose biopsy tract was planned, whose counts have a peri-operative product plan, whose mediastinal mass is not casually sedated, whose family can care for a flank incision or an ostomy, and whose fertility was not an afterthought.